Synergistic antitumor effect of BRMS1 and sorafenib via inhibition of the PI3K/AKT/mTOR/ERK signaling pathway-Reference-Cited by-同舟云学术

Synergistic antitumor effect of BRMS1 and sorafenib via inhibition of the PI3K/AKT/mTOR/ERK signaling pathway

Published:2019-06-24 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Jin Jingyun¹,Guo Yonggang²,Liu Yang³,Wang Zhenguo¹,Yang Xiaosa⁴,Sun Shengkai¹

Affiliation:

1. Department of Medicine and Scientific Research, Characteristic Medical Center of the Chinese People's Armed Police Force, Pingjin Hospital, Tianjin 300162, P.R. China

2. Department of General Surgery Department, Characteristic Medical Center of the Chinese People's Armed Police Force, Pingjin Hospital, Tianjin 300162, P.R. China

3. Department of Neurology, Central Hospital of Minhang, Shanghai 200000, P.R. China

4. Department of Brain, Characteristic Medical Center of the Chinese People's Armed Police Force, Pingjin Hospital, Tianjin 300162, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemopreventive and therapeutic properties of anthocyanins in breast cancer: A comprehensive review;Nutrition Research;2022-11

2. The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy;Journal of Oncology;2022-07-06

3. Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of Tumors;Frontiers in Cell and Developmental Biology;2021-12-20

4. Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer;Chemotherapy;2020-11-25